Anti-MUC2 antibody [996/1]
- BOND RX™ Validated
- Recombinant
- What is this?
4
(5 Reviews)
|
(50 Publications)
Anti-MUC2 antibody [996/1] (ab11197) is a mouse monoclonal antibody detecting MUC2 in Western Blot, IHC-P. Suitable for Human.
- Over 40 publications
- Trusted since 2004
View Alternative Names
SMUC, MUC2, Mucin-2, MUC-2, Intestinal mucin-2
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MUC2 antibody [996/1] (AB11197)
Immunohistochemical analysis of paraffin-embedded human colon tissue labeling MUC2 with ab11197 at 1/5000 dilution followed by a ready to use Goat Anti-Mouse IgG H&L (HRP polymer) (ab214879). The section was incubated with ab11197 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin.
- WB
Lab
Western blot - Anti-MUC2 antibody [996/1] (AB11197)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The molecular weight observed was in consistent with the literature (PMID : 22768227).
All lanes:
Western blot - Anti-MUC2 antibody [996/1] (ab11197) at 1/1000 dilution
Lane 1:
Caco-2 (human colorectal adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
HT1376 (human urinary bladder carcinoma epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/10000 dilution
Observed band size: 100 kDa
false
Exposure time: 180s
- IHC
CiteAb
Immunohistochemistry - Anti-MUC2 antibody [996/1] (AB11197)
Immunohistochemistry-immunofluorescence using Anti-MUC2 antibody [996/1], ab11197. Publication image from Owen, R. P. et al., 2018, Nat Commun, 30323168. Legend direct from paper.
SPINK4 and ITLN1 mark early goblet cells. a Volcano plot showing fold change and P value of genes differentially expressed in the ‘goblet-type’ cell cluster as compared to all other cell clusters (see Fig. 3). Points coloured red indicate genes significant at 5% permutation test. Selected highly significant genes are labelled. b Bar chart showing the percentage of cells in the ‘goblet-type’ cell cluster (n = 98) expressing MUC2, ITLN1 or SPINK4 alone or in different combinations (thresholds set at the tenth centile to include 90% of cells in which at least one transcript was detected from each gene). c Triple immunofluorescence staining images of MUC2 (red), ITLN1 (white) and SPINK4 (green) in normal colon from a resection specimen (blue stain is DAPI). Scale bar, 100 µm. d Triple immunofluorescence staining images of MUC2 (red), ITLN1 (white) and SPINK4 (green) in normal oesophageal epithelium obtained by endoscopic biopsy (blue stain is DAPI). OSGs encroaching on the surface epithelium are shown in the enlarged images on the right. Scale bars are 200 µm and 50 µm in enlarged images. e Triple immunofluorescence staining images of KRT14 (white), KRT7 (green) and MUC2 (red) in an OSG beneath normal squamous epithelium from an endoscopic biopsy of normal squamous epithelium from a patient with BO biopsy (blue stain is DAPI). Scale bar 50 µm. f Representative immunofluorescence staining of Barrett’s EMR specimen containing intestinal metaplasia but no dysplasia for MUC2 (red), ITLN1 (white) and SPINK4 (green); nuclei (DAPI) in blue. Scale bars are 400 µm and 100 µm in enlarged images
- IHC
CiteAb
Immunohistochemistry - Anti-MUC2 antibody [996/1] (AB11197)
Immunohistochemistry-immunofluorescence using Anti-MUC2 antibody [996/1], ab11197. Publication image from Owen, R. P. et al., 2018, Nat Commun, 30323168. Legend direct from paper.
SPINK4 and ITLN1 mark early goblet cells. a Volcano plot showing fold change and P value of genes differentially expressed in the ‘goblet-type’ cell cluster as compared to all other cell clusters (see Fig. 3). Points coloured red indicate genes significant at 5% permutation test. Selected highly significant genes are labelled. b Bar chart showing the percentage of cells in the ‘goblet-type’ cell cluster (n = 98) expressing MUC2, ITLN1 or SPINK4 alone or in different combinations (thresholds set at the tenth centile to include 90% of cells in which at least one transcript was detected from each gene). c Triple immunofluorescence staining images of MUC2 (red), ITLN1 (white) and SPINK4 (green) in normal colon from a resection specimen (blue stain is DAPI). Scale bar, 100 µm. d Triple immunofluorescence staining images of MUC2 (red), ITLN1 (white) and SPINK4 (green) in normal oesophageal epithelium obtained by endoscopic biopsy (blue stain is DAPI). OSGs encroaching on the surface epithelium are shown in the enlarged images on the right. Scale bars are 200 µm and 50 µm in enlarged images. e Triple immunofluorescence staining images of KRT14 (white), KRT7 (green) and MUC2 (red) in an OSG beneath normal squamous epithelium from an endoscopic biopsy of normal squamous epithelium from a patient with BO biopsy (blue stain is DAPI). Scale bar 50 µm. f Representative immunofluorescence staining of Barrett’s EMR specimen containing intestinal metaplasia but no dysplasia for MUC2 (red), ITLN1 (white) and SPINK4 (green); nuclei (DAPI) in blue. Scale bars are 400 µm and 100 µm in enlarged images
- IHC
CiteAb
Immunohistochemistry - Anti-MUC2 antibody [996/1] (AB11197)
Immunohistochemistry-immunofluorescence using Anti-MUC2 antibody [996/1], ab11197. Publication image from Owen, R. P. et al., 2018, Nat Commun, 30323168. Legend direct from paper.
SPINK4 and ITLN1 mark early goblet cells. a Volcano plot showing fold change and P value of genes differentially expressed in the ‘goblet-type’ cell cluster as compared to all other cell clusters (see Fig. 3). Points coloured red indicate genes significant at 5% permutation test. Selected highly significant genes are labelled. b Bar chart showing the percentage of cells in the ‘goblet-type’ cell cluster (n = 98) expressing MUC2, ITLN1 or SPINK4 alone or in different combinations (thresholds set at the tenth centile to include 90% of cells in which at least one transcript was detected from each gene). c Triple immunofluorescence staining images of MUC2 (red), ITLN1 (white) and SPINK4 (green) in normal colon from a resection specimen (blue stain is DAPI). Scale bar, 100 µm. d Triple immunofluorescence staining images of MUC2 (red), ITLN1 (white) and SPINK4 (green) in normal oesophageal epithelium obtained by endoscopic biopsy (blue stain is DAPI). OSGs encroaching on the surface epithelium are shown in the enlarged images on the right. Scale bars are 200 µm and 50 µm in enlarged images. e Triple immunofluorescence staining images of KRT14 (white), KRT7 (green) and MUC2 (red) in an OSG beneath normal squamous epithelium from an endoscopic biopsy of normal squamous epithelium from a patient with BO biopsy (blue stain is DAPI). Scale bar 50 µm. f Representative immunofluorescence staining of Barrett’s EMR specimen containing intestinal metaplasia but no dysplasia for MUC2 (red), ITLN1 (white) and SPINK4 (green); nuclei (DAPI) in blue. Scale bars are 400 µm and 100 µm in enlarged images
- IHC
CiteAb
Immunohistochemistry - Anti-MUC2 antibody [996/1] (AB11197)
Immunohistochemistry-immunofluorescence using Anti-MUC2 antibody [996/1], ab11197. Publication image from Owen, R. P. et al., 2018, Nat Commun, 30323168. Legend direct from paper.
SPINK4 and ITLN1 mark early goblet cells. a Volcano plot showing fold change and P value of genes differentially expressed in the ‘goblet-type’ cell cluster as compared to all other cell clusters (see Fig. 3). Points coloured red indicate genes significant at 5% permutation test. Selected highly significant genes are labelled. b Bar chart showing the percentage of cells in the ‘goblet-type’ cell cluster (n = 98) expressing MUC2, ITLN1 or SPINK4 alone or in different combinations (thresholds set at the tenth centile to include 90% of cells in which at least one transcript was detected from each gene). c Triple immunofluorescence staining images of MUC2 (red), ITLN1 (white) and SPINK4 (green) in normal colon from a resection specimen (blue stain is DAPI). Scale bar, 100 µm. d Triple immunofluorescence staining images of MUC2 (red), ITLN1 (white) and SPINK4 (green) in normal oesophageal epithelium obtained by endoscopic biopsy (blue stain is DAPI). OSGs encroaching on the surface epithelium are shown in the enlarged images on the right. Scale bars are 200 µm and 50 µm in enlarged images. e Triple immunofluorescence staining images of KRT14 (white), KRT7 (green) and MUC2 (red) in an OSG beneath normal squamous epithelium from an endoscopic biopsy of normal squamous epithelium from a patient with BO biopsy (blue stain is DAPI). Scale bar 50 µm. f Representative immunofluorescence staining of Barrett’s EMR specimen containing intestinal metaplasia but no dysplasia for MUC2 (red), ITLN1 (white) and SPINK4 (green); nuclei (DAPI) in blue. Scale bars are 400 µm and 100 µm in enlarged images
Reactivity data
Product details
What is this antibody validated in?
Anti-MUC2 antibody [996/1] (ab11197) is a mouse recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human samples.
What is the molecular weight of MUC2?
Anti-MUC2 [996/1] (ab11197) specifically detects a band for MUC2 (UniProt: Q02817) at a molecular weight of 540kDa.
Trusted by the scientific community
Anti-MUC2 [996/1] (ab11197) was first used in a scientific publication in 2004 and has been cited over 40 times in peer-reviewed journals.
Reviewed by scientists
Anti-MUC2 [996/1] (ab11197) has over 5 independent reviews from customers.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (50)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:30582 PubMed40836050
2025
Applications
Unspecified application
Species
Unspecified reactive species
Lab on a chip 25:1489-1501 PubMed39925127
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biology open 14: PubMed39832187
2025
Applications
Unspecified application
Species
Unspecified reactive species
Annals of surgical oncology 31:5377-5389 PubMed38704503
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nutrients 16: PubMed38612988
2024
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2302113 PubMed38414327
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biotechnology journal 19:e2300390 PubMed38375564
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 14:1142492 PubMed36969163
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell host & microbe 30:1417-1434.e8 PubMed36150396
2022
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 8:eabo4761 PubMed36112689
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com